![]()
|
Report Date : |
03.12.2011 |
IDENTIFICATION DETAILS
|
Name : |
TIRUPATI MEDICARE LIMITED (w.e.f. 13.05.2008) |
|
|
|
|
Formerly Known
as : |
TIRUPATI ZEON MEDICARE LIMITED (w.e.f. 17.07.2007) TIRUPATI MEDICARE LIMITED |
|
|
|
|
Registered
Office : |
D – 14, II ND Floor, Preet Vihar, New Delhi - 110092 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
16.08.2005 |
|
|
|
|
Com. Reg. No.: |
05-139667 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs.6.570 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24233DL2005PLC139667 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELT06301B |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in Manufacturing of Pharmaceutical Formulations. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 420000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track records.
Trade relations are reported as fair. Business is active. Payments are reported
to be usually correct and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
D – 14, II ND Floor, Preet Vihar, New Delhi – 110092, India |
|
Tel. No.: |
Not Available |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
NH – 72, Nahan Road, Paonta Sahib, District – Sirmour – 173025,
Himachal Pradesh, India |
|
Fax No.: |
91-1704-222882 |
|
E-Mail : |
DIRECTORS
As on 20.09.2011
|
Name : |
Mr. Arun Goyal |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
5/227, Shamsherpur, Poanta Sahib, Simour – 173002, Himachal Pradesh, India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
16.08.2005 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00056340 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Ajay Kumar Goel |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Radha Kishan Pharma, Maya Complex, Indra Colony, Krurkshetra – 136118,
Haryana, India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
09.11.2005 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00203434 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Ashok Goyal |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
113, Ward – 4, Mahadev Mohalla, Thanesar, Kurukshetra – 136118,
Haryana, India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
09.11.2005 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00230597 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Gian Chand Goyal |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
5/227, Shamsherpur, Poanta Sahib, Simour – 173002, Himachal Pradesh,
India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
16.083.2005 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
02054181 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Narinder Pal Singh |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Main Bazar, Sirmour - 173025,
Himachal Pradesh, India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
16.08.2005 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
02451588 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 20.09.2011
|
Names of Shareholders |
No. of Shares |
|
Arun Goyal |
25000 |
|
Dinesh Goyal |
9000 |
|
Anju Goyal |
1000 |
|
Gian Chand Goyal |
10000 |
|
Kavita Goyal |
10000 |
|
Narinder Pal Singh |
26500 |
|
Navdeep Kumar |
10000 |
|
Ashok Kumar and Sons, India |
18500 |
|
Sunil Kumar and Sons, India |
22000 |
|
Aditya Antibiotics Private Limited, India |
5000 |
|
Ajay Goel |
63500 |
|
Ashok Goyal |
74000 |
|
Alka Shah |
12750 |
|
Ashok Kumar Shah |
10000 |
|
Madhu Shah |
4250 |
|
Sunil Shah |
6500 |
|
Enpro Gas Company Private Limited, India |
5000 |
|
International Cylinder, India |
253000 |
|
Manish Bansal |
5000 |
|
Mohit Bansal |
4000 |
|
Rakhi Goyal |
7000 |
|
Rani Sufla |
20000 |
|
R. S. Associates, India |
5000 |
|
Maya Industries, India |
50000 |
|
Total |
657000 |
Equity Share Break up (Percentage of Total Equity)
As on 20.09.2011
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in Manufacturing of Pharmaceutical Formulations. |
GENERAL INFORMATION
|
Customers : |
·
Cipla Limited ·
Ranbaxy ·
Abbott India Limited ·
Micro Labs Limited ·
Ipca Laboratories Limited ·
Alkem Laboratories Limited ·
Meyer Organices Private Limited ·
Sun Pharmaceutical Industries Limited ·
Glenmark Pharmaceuticals Limited ·
Wanbury Limited ·
Geno Pharmaceuticals Limited ·
Ajanta Pharma Limited ·
Universal Medicare Private Limited |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
Not Available |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
·
Punjab National Bank, MID Corporate Branch,
Sector 17 B, Chandigarh – 160017, India ·
State Bank of India, Taruwala, Paonta Sahib –
173025, Himachal Pradesh, India ·
HDFC Bank |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
|
Financial Institute : |
TML Finance Service Limited |
|
|
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Vikas Garg Chartered Accountant |
|
Address : |
SCO – 12, Sector – 17, Near LIC Building, Kurukshetra – 136118,
Haryana, India |
|
PAN.: |
ABEPG4282B |
|
|
|
|
Group Companies : |
·
Tirupati Lifesciences ·
Newtramax Healthcare ·
International Cylinder Private Limited ·
Tirupati LPG Industries Limited ·
Tirupati Cylinders Limited ·
Spice Hotel |
CAPITAL STRUCTURE
As on 31.03.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1000000 |
Equity Shares |
Rs.10/- each |
Rs.10.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
657000 |
Equity Shares |
Rs.10/- each |
Rs.6.570
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
6.570 |
6.570 |
47.320 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
100.429 |
73.661 |
0.048 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
106.999 |
80.231 |
47.368 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
259.602 |
186.275 |
144.318 |
|
|
2] Unsecured Loans |
37.740 |
42.980 |
43.177 |
|
|
TOTAL BORROWING |
297.342 |
229.255 |
187.495 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
404.341 |
309.486 |
234.863 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
231.608 |
216.347 |
197.221 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.780 |
0.667 |
0.472 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
113.165
|
79.938 |
30.157 |
|
|
Sundry Debtors |
171.629
|
116.397 |
58.919 |
|
|
Cash & Bank Balances |
0.886
|
1.009 |
0.540 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
10.812
|
7.182 |
4.027 |
|
Total
Current Assets |
296.492
|
204.526 |
93.643 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
110.199
|
102.111 |
53.601 |
|
|
Other Current Liabilities |
8.347
|
5.732 |
2.762 |
|
|
Provisions |
6.094
|
4.327 |
0.190 |
|
Total
Current Liabilities |
124.640
|
112.170 |
56.553 |
|
|
Net Current Assets |
171.852
|
92.356 |
37.090 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.101 |
0.116 |
0.080 |
|
|
|
|
|
|
|
|
TOTAL |
404.341 |
309.486 |
234.863 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
800.404 |
456.094 |
138.215 |
|
|
|
Other Income |
0.000 |
0.000 |
0.000 |
|
|
|
TOTAL (A) |
800.404 |
456.094 |
138.215 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Accretion (Depletion) in stock |
(1.967) |
(4.159) |
0.002 |
|
|
|
Manufacturing/ Direct Expenses |
646.262 |
365.579 |
106.313 |
|
|
|
Administrative Expenses |
76.814 |
30.995 |
12.472 |
|
|
|
Selling and Distribution Expenses |
7.145 |
7.119 |
2.635 |
|
|
|
Preliminary Expenses |
0.015 |
0.015 |
0.010 |
|
|
|
TOTAL (B) |
728.269 |
399.549 |
121.432 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
72.135 |
56.545 |
16.783 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
31.972 |
22.754 |
12.816 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
40.163 |
33.791 |
3.967 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
10.301 |
8.601 |
3.730 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE TAX
(E-F) (G) |
29.862 |
25.190 |
0.237 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
9.966 |
8.177 |
0.190 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
19.896 |
17.013 |
0.047 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
17.061 |
0.048 |
0.001 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
36.957 |
17.061 |
0.048 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
30.28 |
25.89 |
0.08 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
2.48
|
3.73 |
0.03 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
3.73
|
5.52 |
0.17 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
5.65
|
5.98 |
0.08 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.28
|
0.31 |
0.01 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.94
|
4.25 |
5.15 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.37
|
1.82 |
1.65 |
LOCAL AGENCY FURTHER INFORMATION
FORM 8
|
Corporate identity number of the company |
U24233DL2005PLC139667 |
|
Name of the company |
TIRUPATI MEDICARE LIMITED |
|
Address of the registered office or of the
principal place of business in |
D-14 II ND Floor, Preet Vihar, New Delhi –
110092, India Email Id : vikas_ca35@yahoo.co.in |
|
This form is for |
Creation of charge |
|
Type of charge |
Uncalled share capital Immovable property Any interest in immovable property Book debts Movable property
(not being pledge)\ Current assets
and fixed assets |
|
Particular of charge holder |
State Bank of India, Taruwala, Paonta
Sahib – 173025, Himachal Pradesh, India Email Id : sbi.04589@sbi.co.in |
|
Nature of instrument creating charge |
Letter of Arrangement Agreement of Loan cum Hypothecation |
|
Date of instrument Creating the charge |
27.04.2011 |
|
Amount secured by the charge |
Rs.308.900 Millions |
|
Brief of the principal terms an conditions
and extent and operation of the charge |
Rate of Interest on working capital @ 3.75 % above base
rate on term loan @ 4.25 % above base rate Terms of Repayment working capital loan repayable on demand Term Loan for Rs.83.600 and Rs.18.800
Millions will be repayable in remaining 60 monthly installments along with
interest w.e.f. April 2011 Margin Stock 25% Book Debts 25% ILC/PLC 15% Extent and operation of the charge FBWC Limit for Rs.200.000 Millions Term Loan-1 for Rs.83.600 Millions Term Loan-2 for Rs.18.800 Millions SME Credit Plus Rs.2.000 Millions SME Car Loan Rs.2.000 Millions ILC/FLC Limit For Rs.2.500 Millions |
|
Short particulars of the property or
asset(s) charged (including complete address and location of the property) |
Hypothecation of all current assets of
company including raw material stock in process finished goods consumables book
debts/receivables etc Hypothecation of entire fixed assets of
company(present and future) Equitable Mortgage of Factory Land
Measuring 8 Bigha 19 Biswa and Building situated at Mauza Patlian Nh72 (Near
Fire Station) Village Patlian Nahan Road Paonta Sahib in the name of the
company Equitable Mortgage of
Industrial/commercial land mesauring 2 Bigha 18 Biswa Bearing Khatoni No.
71/109 Khasra No. 390/334/9/4/1 at NH 72(Near Fire Station) Paonta Sahib In
The Name of SH. Arun Goyal Equitable Mortgage of
Industrial/commercial land mesauring 7 Bigha 3 Biswa Bearing Khatoni No.
71/109 Khasra No. 390/334/9/3 at NH 72 (Near Fire Station) Paonta Sahib in
the name of Gian Chand Goyal Equitable Mortgage of Land Mesauring 14
Biswa Bearing Khatoni No. 83/124 Khasra No. 13/1 at NH 72 (Near Fire Station)
Paonta Sahib in the name of Gian Chand
Goyal Extension of charge on fixed assets of the
company |
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.35 |
|
|
1 |
Rs.80.51 |
|
Euro |
1 |
Rs.69.14 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.